Product Usage: For Research Use Only – Not for Human or Veterinary Use
This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA. It is strictly intended for in vitro research by qualified professionals. Any use in humans or animals is strictly prohibited and may violate federal, state, or local laws, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic application is implied or permitted. The purchaser assumes all responsibility for compliance with applicable regulations.
Glow Blend Capsules
Oral capsules combining GHK-Cu, BPC-157, TB-500, and Hyaluronic Acid, four compounds studied individually in published research for cellular-signaling and tissue-related processes. Supplied at research-grade purity for laboratory use only.
$275.00
Glow Blend Capsules combine four individually documented ingredients — GHK-Cu, BPC-157, TB-500 (Thymosin Beta-4), and Hyaluronic Acid — each studied in its own body of published research for interaction with cellular-signaling and tissue-related biological processes. Researchers combine compounds such as these to study multiple tissue-related pathways in parallel; the summary below describes each component’s own published research individually. No combined-formulation study of this specific blend is described or implied.
What is in Glow Blend Capsules?
GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine) studied extensively, particularly by researcher Loren Pickart and colleagues, for its association with collagen and glycosaminoglycan synthesis measures, wound-healing models, and antioxidant/anti-inflammatory gene-expression signatures in skin-cell and animal models.
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a body-protection-compound protein fragment. Published preclinical research, much of it from a research group based in Croatia, has examined BPC-157’s association with angiogenesis measures, tendon- and ligament-healing models, and gastrointestinal-mucosa protection in rodent injury models.
TB-500 (Thymosin Beta-4)
Thymosin Beta-4 is a naturally occurring actin-regulatory peptide studied for its role in cell-migration-dependent processes. Preclinical research in animal injury models has reported associations between Tβ4 administration and wound-closure and angiogenesis-marker measures, described in more detail in First Class Science’s dedicated TB-500 product research summary.
Hyaluronic Acid
Hyaluronic acid is a naturally occurring glycosaminoglycan present throughout connective, epithelial, and neural tissue, well documented in the scientific literature for its role in tissue hydration and extracellular-matrix structure. It is commonly studied, including in topical and oral research contexts, for its association with tissue-hydration and matrix-related measures.
Purity & Quality
First Class Science supplies Glow Blend Capsules at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://firstclassscience.com/certificate-of-analysis/. Store in a cool, dry place away from direct sunlight and moisture; keep out of reach of children.
Important: This item is manufactured strictly for research purposes. It is not intended for human or veterinary use and is distributed solely for laboratory and scientific investigation.
Research Applications
Tissue-Repair & Extracellular-Matrix Research (GHK-Cu, Hyaluronic Acid)
GHK-Cu has been studied for its association with collagen-synthesis and antioxidant gene-expression measures in skin-cell and animal wound models, while hyaluronic acid’s well-characterized role in extracellular-matrix hydration has made it a frequent reference point in tissue-structure research. Researchers studying tissue-repair pathways sometimes examine copper-peptide and glycosaminoglycan biology in parallel given their overlapping relevance to connective-tissue research models.
Cellular Signaling & Angiogenesis Research (BPC-157, TB-500)
Both BPC-157 and Thymosin Beta-4 have been individually studied in preclinical animal-injury models for their association with angiogenesis markers and tissue-repair-related measures, each through distinct proposed mechanisms — BPC-157 through growth-factor and vascular-signaling pathways, and Thymosin Beta-4 through actin-regulated cell migration. This research remains preclinical for both compounds.
Disclaimer: The research summarized above is drawn from third-party published studies conducted in animal, in vitro, or non-U.S. clinical contexts. It is provided for research and educational reference only and does not describe an intended use, effect, or benefit of this product for any person or animal.
⊗ ALL ITEMS ARE SOLD FOR RESEARCH USE ONLY. This category covers strictly in vitro laboratory testing and scientific experimentation. Content on this site is for education only and does not authorize human or animal use of any kind, which is prohibited by law. Only trained, licensed professionals should handle these materials. Nothing sold here qualifies as a drug, food, or cosmetic, and none of it may be labeled, advertised, or used as such.